New York
Medicare Migraine Prescribing Gap Report
86.6%
of primary care physicians actively prescribing triptans to Medicare patients in New York have never prescribed a CGRP medication
How New York compares
New York's 86.6% gap is 3.8 points below the national average of 90.4%. 700 of 808 primary care physicians with an active Medicare migraine patient panel have never written a CGRP prescription.
Metro breakdown
About the data
Based on CMS Medicare Part D prescribing data — the only publicly available provider-level prescribing dataset in the United States. Active prescriber = 20+ triptan claims in the observation period. Medicare patients represent a subset of the total migraine population; the true gap is likely larger. Full methodology →
What drives the gap
Prior authorization burden is the primary structural explanation for this gap. The Headache Vault's PA Engine helps primary care physicians navigate CGRP prior authorizations in New York and all 50 states — free for all clinicians.
Try the PA Engine →Citation
Doty A. Migraine Prescribing Gap in New York. The Headache Vault; 2026. Available at: https://headachevault.com/research/prescribing-gap/new-york/ Licensed CC BY 4.0. Data: CMS Medicare Part D Prescriber Public Use Files, 2022-2023.